| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 05/18/2011 | CN101065372B 1-alkynyl-2-aryloxyalkylamides and their use as fungicides |
| 05/17/2011 | US7943787 Preparation of pentafluorosulfanyl (SF5) heterocycles: pyrroles and thiophenes |
| 05/17/2011 | US7943654 1H-thieno[2,3-c]pyrazole compounds useful as kinase inhibitors |
| 05/17/2011 | US7943603 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 05/17/2011 | CA2493776C Process for producing n-monoalkyl-3-hydroxy-3-(2-thienyl)propanamine and intermediate |
| 05/12/2011 | WO2011055529A1 Heterocycle-containing asymmetric aromatic compound, compound for organic thin film transistor, and organic thin film transistor using same |
| 05/12/2011 | WO2011055378A1 Improved process for preparation of clopiodogrel bisulfate crystalline form-1 |
| 05/12/2011 | WO2011055142A2 1,4-quinones and their sulfur analogues useful as ligands of n-acetyltransferases |
| 05/12/2011 | WO2011020712A3 Oligothiophenes derivatives |
| 05/12/2011 | US20110112311 Method for producing 3-methyl-2-thiophenecarboxylic acid |
| 05/12/2011 | US20110112180 Novel stat3 pathway inhibitors and cancer stem cell inhibitors |
| 05/12/2011 | US20110112166 Therapeutic cyclopentane derivatives |
| 05/12/2011 | US20110112081 Inhibitors of janus kinases |
| 05/12/2011 | US20110108826 Anthracene derivative and an organic electronic device using the same |
| 05/12/2011 | CA2780149A1 Ire-1.alpha. inhibitors |
| 05/11/2011 | EP2319890A1 Azo compound, azo pigment, pigment dispersion, color composition, inkjet recording ink, color composition for color filter, color filter, and method for preparing color composition for color filter |
| 05/11/2011 | EP2319840A1 Aminopropylidene derivative |
| 05/11/2011 | EP2318368A1 1-(4-ureidobenzoyl)piperazine derivatives |
| 05/11/2011 | EP2134699B1 2-aryl-5-heterocyclyl-cyclohexane-1,3-dione compounds and their use as herbicides |
| 05/11/2011 | EP1320520B1 Sulfonylguanidine |
| 05/11/2011 | CN1665801B Anti tubercular drug: compositions and methods |
| 05/11/2011 | CN102056958A Polymer compound and organic transistor using the polymer compound |
| 05/11/2011 | CN102056914A Process for the preparation of 3,4-dihydro-2H-thien[3,2-E]-1,2-thiazin-4-ol 1, 1-dioxide derivatives and intermediates |
| 05/11/2011 | CN102056897A Sulfonamide compound and application thereof |
| 05/11/2011 | CN102050812A 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 05/11/2011 | CN102050811A 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 05/11/2011 | CN102050758A Novel amide derivatives and medicinal use thereof |
| 05/11/2011 | CN102050689A Method for preparing beta-amino-alpha,beta unsaturated ester |
| 05/11/2011 | CN102050688A Asymmetric catalytic hydrogenation method for ketone-derived N-alkylimine |
| 05/11/2011 | CN101497610B Dithiazole ethylene compound containing 2,1,3-diazosulfide unit |
| 05/11/2011 | CN101124196B Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols |
| 05/10/2011 | US7939666 Enzyme inhibitors |
| 05/10/2011 | US7938641 Extrusion die |
| 05/10/2011 | CA2524602C Improved seal swell agent and process therefor |
| 05/10/2011 | CA2436935C Serine protease inhibitors |
| 05/05/2011 | WO2011033366A8 Improved process for the preparation of duloxetine and its pharmaceutically acceptable salt |
| 05/05/2011 | WO2005060456A9 Method for treating adamts-5-associate disease |
| 05/05/2011 | US20110106241 Compositions and methods for inhibiting sphingosine kinase |
| 05/05/2011 | US20110105758 Process for the preparation of enantiomerically enriched cyclic beta-aryl or heteroarylcarbocyclic acids |
| 05/05/2011 | US20110105597 Modulation of pathogenicity |
| 05/05/2011 | US20110105572 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 05/05/2011 | US20110105571 Opioid Receptor Antagonists |
| 05/05/2011 | US20110105564 Thienylpyridylcarboxamides |
| 05/05/2011 | US20110105554 Means for treating myosin-related diseases |
| 05/05/2011 | US20110105544 Carboxylic derivatives for use in the treatment of cancer |
| 05/05/2011 | US20110105533 Heterocyclic Sulfonamides, Uses and Pharmaceutical Compositions Thereof |
| 05/05/2011 | US20110105485 Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors |
| 05/05/2011 | US20110104162 Compounds which can be used for the Treatment of Cancers |
| 05/05/2011 | US20110102970 Monomers of selected colour numbers and capacitors prepared therefrom |
| 05/04/2011 | EP2315746A1 Urea derivatives as antibacterial agents |
| 05/04/2011 | EP1660471B1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 05/04/2011 | EP1481967B1 Process for the preparation of biaryl compounds |
| 05/04/2011 | CN102046601A Benzene or thiophene derivative and use thereof as VAP-1 inhibitor |
| 05/04/2011 | CN102046598A Novel donor-acceptor fluorene scaffolds : a process and uses thereof |
| 05/04/2011 | CN102040589A Condensed-cyclic compound and organic light emitting diode |
| 05/04/2011 | CN102040585A Selective estrogen receptor regulator |
| 05/03/2011 | US7935960 organic field effect transistors; introducing asymmetry into the polyacene derivative affects its solid-state order; combining with organic binder resin results in little or no reduction in charge mobility of the polyacene, even an increase in some instances |
| 05/03/2011 | US7935724 Thiophene and benzothiophene hydroxamic acid derivatives |
| 05/03/2011 | US7935696 e.g. 5-(4-Chlorophenyl)-N-(5-(cyclopropylcarbamoyl)-2-methylphenyl)furan-2-carboxamide; p38 alpha and beta kinase inhibitor; antiinflammatory agent; asthma, inflammatory bowel disease, osteoporosis, psoriasis, graft vs. host rejection, atherosclerosis, multiple myeloma, pain, myocardial ischemia |
| 05/03/2011 | CA2438480C Glucocorticoid receptor modulators |
| 04/28/2011 | WO2011049213A1 Fused heterocyclic compound and thrombopoietin receptor activator |
| 04/28/2011 | WO2011048004A1 Inhibitors of the microsomal prostaglandin e2 synthase-1 |
| 04/28/2011 | WO2011047878A2 A process for preparing benzo[b]thiophene derivatives |
| 04/28/2011 | WO2011047877A1 A process for preparing benzo[b]thiophene derivatives |
| 04/28/2011 | WO2011047432A1 Fused ring analogues of anti-fibrotic agents |
| 04/28/2011 | WO2011023791A3 Method for producing organoaluminium compounds and use thereof |
| 04/28/2011 | US20110098485 Bidentate secondary phosphine oxide chiral ligands for use in asymmetric addition reactions |
| 04/28/2011 | US20110098484 Process for production of 1-(3-(2-(1-benzothiophen-5-yl)- ethoxy)propyl)azetidin-3-ol or salts thereof |
| 04/28/2011 | US20110098480 Activating agent for peroxisome proliferator activated receptor |
| 04/28/2011 | US20110098309 Methods of inhibiting the formation of amyloid-beta diffusable ligands using acylhydrazide compounds |
| 04/28/2011 | DE102010047404A1 Verbindungen für ein flüssigkristallines Medium und Verwendung für Hochfrequenzbauteile Connections for a liquid crystalline medium and high frequency components for use |
| 04/27/2011 | EP2314593A1 Platelet ADP receptor inhibitors |
| 04/27/2011 | EP2314581A1 A process for preparing benzo[b]thiophene derivatives |
| 04/27/2011 | EP2314568A2 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives |
| 04/27/2011 | EP1971592B1 Improved synthesis and preparations of duloxetine salts |
| 04/27/2011 | EP1534661B1 Spirobifluorene derivatives, their preparation and uses thereof |
| 04/27/2011 | EP1383463B1 Fused thiophene compounds and use thereof in the treatment of chronic pain |
| 04/27/2011 | CN1993346B Thiophene compound |
| 04/27/2011 | CN102036980A Substituted thiophenecarboxamides as IKK-beta serine-, threonine-protein kinase inhibitors |
| 04/27/2011 | CN102036979A Inhibitors of IKK-beta serine-theronine protein kinase |
| 04/27/2011 | CN102036978A Novel thiophenediamine derivative having urea structure |
| 04/27/2011 | CN102036953A Arylsulfonamide-based matrix metalloprotease inhibitors |
| 04/27/2011 | CN102036946A Co-crystals of duloxetine and Cox-inhibitors for the treatment of pain |
| 04/27/2011 | CN102034933A Photoelectric conversion device, photoelectric conversion device material, photosensor and imaging device |
| 04/27/2011 | CN102030700A Benzamide carboxylic acid compound as well as manufacturing method and medicinal application thereof |
| 04/27/2011 | CN101274927B Photochemical reaction preparation for quaternary ring compound and use of the quaternary ring compound |
| 04/26/2011 | US7932392 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 04/26/2011 | US7931696 Cationic dyes |
| 04/26/2011 | CA2477657C Cathepsin cysteine protease inhibitors |
| 04/26/2011 | CA2446461C Substituted cyclohexane-1,4-diamine derivatives |
| 04/26/2011 | CA2376064C Factor viia inhibitors |
| 04/26/2011 | CA2345103C (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 04/21/2011 | WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses |
| 04/21/2011 | WO2011045355A1 Novel microbiocides |
| 04/21/2011 | WO2011045259A1 Aminopropenoates as fungicides |
| 04/21/2011 | WO2010150988A3 Anthracene derivatives and organic electroluminescence device using same |
| 04/21/2011 | WO2010147318A3 Aminoanthracene derivative and an organic electroluminescent element employing the same |
| 04/21/2011 | WO2008080988A3 Cyclopentanone derivatives, method of synthesis and uses thereof |
| 04/21/2011 | US20110092612 Photoreactive composition, optical material, composition for forming holographic recording layer, holographic recording material, and holographic recording medium |
| 04/21/2011 | US20110092578 Broad Spectrum Gram-Positive Antimicrobials and Anthelmintics with Efficacy Against Drug-Resistant Strains and Mycobacterium Species |